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Abstract
Background: Severe intraventricular hemorrhage (IVH) is one of the most devastating neurological complications in
preterm infants, with the majority suffering long-term neurological morbidity and up to 50% developing post-hem‑
orrhagic hydrocephalus (PHH). Despite the importance of this disease, its cytopathological mechanisms are not well
known. An in vitro model of IVH is required to investigate the effects of blood and its components on the developing
ventricular zone (VZ) and its stem cell niche. To address this need, we developed a protocol from our accepted in vitro
model to mimic the cytopathological conditions of IVH in the preterm infant.
Methods: Maturing neuroepithelial cells from the VZ were harvested from the entire lateral ventricles of wild type
C57BL/6 mice at 1–4 days of age and expanded in proliferation media for 3–5 days. At confluence, cells were re-plated
onto 24-well plates in differentiation media to generate ependymal cells (EC). At approximately 3–5 days, which corre‑
sponded to the onset of EC differentiation based on the appearance of multiciliated cells, phosphate-buffered saline
for controls or syngeneic whole blood for IVH was added to the EC surface. The cells were examined for the expres‑
sion of EC markers of differentiation and maturation to qualitatively and quantitatively assess the effect of blood
exposure on VZ transition from neuroepithelial cells to EC.
Discussion: This protocol will allow investigators to test cytopathological mechanisms contributing to the pathol‑
ogy of IVH with high temporal resolution and query the impact of injury to the maturation of the VZ. This technique
recapitulates features of normal maturation of the VZ in vitro, offering the capacity to investigate the developmental
features of VZ biogenesis.
Keywords: Cell culture, Neural stem cells, Ependyma, Ventricular zone, Intraventricular hemorrhage, Posthemorrhagic hydrocephalus, Preterm, Premature, Neonate
Introduction
Intraventricular hemorrhage (IVH) is a severe neurological disorder of preterm infants, affecting about 20
percent of the preterm infants born at or below 32 gestational weeks [1]. Up to one half of infants with IVH
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develop post-hemorrhagic hydrocephalus (PHH), which
is the most common etiology of pediatric hydrocephalus
in North America [2]. Despite advances in the medical
and surgical care of these infants, the prognosis of preterm IVH with PHH shows unacceptable high rates of
persistent neurocognitive deficits (up to 85%) and cerebral palsy (up to 70%) [3]. Current treatment methods
focus on draining cerebrospinal fluid (CSF) to reduce
the excess pressure regardless of hydrocephalus etiology.
There have been no substantive advances in the treatment
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of PHH in recent years, and few viable targeted therapeutic strategies have been proposed. To improve the care
and outcomes for these patients, we must first define the
fundamental mechanisms underlying the pathophysiology of IVH and its sequelae, and develop experimental
models for testing therapeutic interventions.
An association between IVH, PHH, and neurodevelopmental impairment is well-established, but the
mechanisms linking these disorders remain unclear.
Recent evidence implicates impairment of cell junction
complexes within the ventricular zone (VZ) [4–10] with
associated ciliopathy in the etiology of congenital, nonhemorrhagic hydrocephalus [11–19] in both experimental models [4–6, 10, 11, 20–24] and humans [25–28].
VZ disruption is also identified as a key feature in IVH
in humans [29]. Therefore, an understanding of the complex effects of the blood on the VZ is needed to develop
preventive treatments for neurological sequelae of IVH/
PHH. This protocol describe an in vitro experimental
strategy that provides the ability to control the environment of murine VZ development. The reductionist
approach allows a rapid and direct method to address
questions related to mechanisms and effects of bloodrelated VZ disruption with high temporal and physiological resolution.
The methods detailed herein are uniquely applied to
IVH, PHH, or hydrocephalus more generally. While other
groups have cultured ependymal cells (EC) previously
[30, 31], the notion of using VZ cultures to study the
effects of IVH is a novel strategy reported from our group
[32]. This protocol is a major step forward in IVH/PHH
research, as it enables rigorously controlled mechanistic
experiments, with the added flexibility of mimicking various human physiological parameters. For example, studies of the VZ from patients with PHH [29] and congenital
hydrocephalus [27, 28] indicate that alterations in adherens junction molecules play an important role in EC
damage. Furthermore, the VZ culture system eliminates
problems such as drug bioavailability, the blood brain
barrier, and it allows high-throughput testing of the effect
of drugs. Testing of pharmacological agents in vitro is an
important first step to not only assess efficacy but also
determine optimal ranges of dosing prior in vivo testing.
It is well known that normal multiciliated EC differentiate from monociliated stem cells; however, the
complex developmental mechanisms governing this
process are still not completely clear. For example, how
polarity is established in multiciliated EC and how trafficking of adhesion molecules to the cell membrane
occurs, requires further study. Our model will be useful for the study of normal developmental neurobiological processes, the myriad of secondary newborn
brain disorders (e.g. hypoxia, inflammation, nutrition
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and metabolic disorders), and therapeutics explorations designed to mitigate the neurological effects of
VZ injury.
The VZ is a layer of tissue mainly composed of neurostem cells that line the fetal ventricular system [33, 34].
This layer is a proliferative area involved in the neurogenesis (intermediate progenitors, neurons) and gliogenesis (astrocytes, oligodendrocytes, ependymocytes)
[35] of the brain; therefore representing an important
platform for brain development. Our model enables
investigation of the effect of blood on these precursor
cells and specifically the impact on differentiation from
VZ to multiciliated EC, the final step in the transition
of the VZ. EC are involved in control of fluid movement
between brain extracellular space and the CSF, in part
to clear metabolites from the interstitial fluid [36]. EC
also promote localized movement of fluid and its contents within the ventricles through the synchronized
beating of cilia [37]. In fact, deficits in the formation
of cilia cause serious disorders in the central nervous
system, including hydrocephalus (reviewed in [38–40]).
Despite the importance of the VZ in brain development, there are few reported methods to differentiate
EC from brain neural stem cells (NSC) [30, 41–43]. We
have recently reported on the effects of syngeneic blood
on the VZ using an in vitro model [32], but the details
of our procedures have not been published.

Materials and methods
All procedures were approved by the Washington University Animal Care and Use Committee according
to the Guide for the Care and Use of Laboratory Animals, NRC 2011.
Telencephalic lateral wall dissection (modified [30]
and [31])
Materials

• C57BL/6 mice age P0–P4 (Jackson Labs, Bar Harbor, ME).
• Mayo and Metzenbaum surgical scissors.
• Single-edge razor blade.
• Ultrafine surgical forceps (PT-31 super fine tip
non-flex tweezers, Precise Hand Tools, London).
• Stereo microscope.
• Petri dish (10 cm2).
• Hank’s Balanced Salt Solution (HBSS) (#14170-112,
Gibco, Waltham, MA), 1% penicillin, streptomycin,
amphotericin B (PSA) (#30-004-CI, Corning Life
Sciences, Corning, NY).
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Procedure

• Expose P0-P4 C57BL/6 mice to wet ice for 2 min
or until the pup is not responsive or use methods
as guided by the local IACUC for terminal studies.
Once circulatory arrest by cooling is achieved, euthanize the pup by removing the head and gently strip
the scalp.
• Remove the brain through a lateral incision from the
foramen magnum toward the external auditory canal
(~ 3 mm) and a superficial sagittal incision from
the foramen magnum all the way through the midline using Metzenbaum surgical scissors. After that
remove the frontal and parietal bones with curved
surgical forceps.
• Deposit the brain in a Petri dish cooled in ice with
HBSS, 1% PSA.
• Working under a stereomicroscope, dissect both
cortical hemispheres, as well as the brainstem and
the olfactory bulbs by cutting in the midline using a
single-edge razor blade (Fig 1).
• Position the medial hemispheric side superiorly and
using ultrafine forceps, introduce one tip into the lateral ventricle in an anteroposterior direction all the
way through the ventricle until the para-hippocampal
gyrus is reached. Keep the opposite tip of the forceps

Page 3 of 11

in a ventral position regarding the anatomical orientation of the brain hemisphere, and close the forceps completely, producing an incision that divides
the hippocampus and thalamus from the lateral
wall. With a single, gentle twist of the wrist, remove
the hippocampus and thalamus from the lateral wall
(Fig. 1). Peel the meninges off the surface of the cerebral cortex, grasping them at the edge of the hemisphere and pulling away of the hemisphere. The wall
dissection should not take longer than an hour and
the tissue must not be stored or frozen before carrying out the VZ cell culture.

Ventricular zone cell culture (modified from [30])
Materials

• Poly-l-Lysine (P4707, Sigma, St. Louis, MO), Autoclaved H2O.
• Enzymatic solution: 1 mL Dulbecco’s Modified
Eagle’s Medium (DMEM) 1% glutamax, 1% PSA, 17.1
µL papain (#37A17241, Worthington, Lakewood,
OH), and 288 µg l-Cysteine (#C7352, Sigma, St.
Louis, MO) for each brain dissected.
• Ca2+/Mg2+ free PBS Trypsin EDTA.

Fig. 1 Dissection of the lateral ventricular wall to obtain VZ cells. Photographs of mouse brain gross morphology to illustrate isolation of the lateral
ventricle wall using the following steps: (1) The brain is divided in the midline (dashed line) using a dorsal approach. (2) With the midsagittal surface
down, the cerebral hemisphere is separated from the cerebellum (dashed line). (3) Beginning at the midsagittal surface, one sharp tip of ultrafine
forceps is inserted into the dorsal lateral ventricle through the septum(s) between the anterior corpus callosum (CC) and the fornix (Fo), and angled
so that the tip exits the occipital pole of the cerebral hemisphere; the other arm of the forceps should be external to the ventral surface of the
brain. When the para-hippocampal gyrus is reached, the forceps are closed to detach the thalamus (T) and hippocampus medially from the lateral
cerebral cortex. (4) By opening the lateral cerebral cortex, lateral wall of the ventricle (LW) is visualized and dissected to provide tissue for cell culture
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• Decomplemented FBS (heat inactivated, 55 °C one
hour).
• Stop solution: 500 µL (10 mg/mL) of trypsin inhibitor (#10,109,878,001, Roche, Basel, Switzerland) in
PBS (0.05% BSA) and 200 µL of DNAase I (#EN0521,
Thermo Fisher Scientific, Waltham, MA) in 10 mL of
L-15 medium (Leibovitz’s L15, #11415-064, Thermo
Fisher Scientific, Waltham, MA) up to 9 brains.
• Proliferation medium: DMEM (#11965-092, Gibco,
Waltham, MA), 1% glutamax (#35050-061, Gibco,
Waltham, MA), 1% PSA (#MT 30-004-CI, Thermo
Fisher Scientific, Waltham, MA), 10% Fetal Bovine
Serum (FBS, #100-106, Gemini Bi-Products, Sacramento, CA).
• 15 mL Falcon tubes.
• Single-edge razor blades.
• Differentiation medium: DMEM, 1% glutamax, 1%
PSA.
• Laminar flow hood.
• Tissue culture incubator 37 °C and 5% CO2.
• Centrifuge capable of holding 15 mL tubes.
• Hemocytometer.
• Inverted tissue culture microscope.
• 24-well tissue culture plate.
• Coverslips (#CLS1763012, 12 mm round coverslips,
Chemglass Life Sciences, NJ).

Procedure

• Coat a 25 cm2 flask with 1 mL Poly-l-Lysine for at
least 1 h. Rinse the flask 3 times with autoclaved H
 2O
and let dry under the laminar flow hood.
• Under a laminar flow hood, cut the dissected lateral walls in small pieces using the single edge razor
blade until each piece can pass through a 1000 µL
pipet tip.
• Deposit the tissue in a 15 mL Falcon tube and centrifuge for 1 min at 105×g. Remove the supernatant and
add the enzymatic solution for 55 min at 37 °C and
5% CO2 within a standard tissue culture incubator.
• Centrifuge for 1 min 105×g, remove the supernatant
and add the stop solution for 2 min.
• Centrifuge for 1 min 105×g and remove supernatant.
Wash by adding 10 mL of L15.
• Centrifuge for 1 min 105×g, remove the supernatant
and add 1 mL of L15 and disaggregate the cells by
pipetting (no more 15 times).
• Centrifuge for 7 min 105×g, remove supernatant and
add 1 mL of proliferation medium per brain used.
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• Add three mL of proliferation medium with cells into
every coated 25 cm2 flask and incubate at 37 °C and
5% CO2. Change the media the next day.
• When confluence reaches 80–100% (3–4 days),
shake the flask at 250 RPM overnight and remove the
medium to separate differentiated from non-differentiated cells (stem cells) remaining in the flask. Wash
the cells in the flask three times with Ca2+/Mg2+ free
PBS.
• Add 1 mL of trypsin EDTA for 5 min at 37 °C, 5%
CO2 to detach the stem cells. After confirming that
the cells have detached under the microscope, add
1 mL of decomplemented FBS to stop the trypsin
activity. Avoid exposure to trypsin for more than
5 min.
• Quantify total number of cells using a hemocytometer. Centrifuge for 7 min 105×g, remove the supernatant and add proliferating media to a concentration
of 2 × 106 cells per mL.
• For further analysis by western blot, add 50 µL of the
stem cells (10 × 104 cells) into sterile 24 well plates;
for analysis with immunocytochemistry, add a 25 µL
(5 × 104 cells) drop onto 12 mm coverslips inside the
24 well plates. (Pre-coated coverslips or wells with
Poly-l-Lysine, see step [Coat a 25 cm2 flask with 1
mL Poly-l-Lysine…] in “Procedure” section). Incubate the drop for 1 h at 37 °C, 5% C
 O2; then add 1 mL
of proliferative medium.
• On the next day, change the media to differentiation
medium (1 mL). Renew the media every other day.
From this point onward, the cells will progressively
differentiate from stem cells to multiciliated EC. On
days 3, 5, 7 and thereafter, the differentiation medium
is added. About 4%, 23% and 52% of the cells, at days
3, 5, 7, respectively, should be multiciliated [32]. The
cultures will remain stable for 10–12 days.
• After cervical dislocation, extract blood from
3-month-old mice through an orbital sinus puncture
(reviewed by [44]; this age corresponds to the most
feasible time to obtain the quantity of blood required
for 24 well-plates. Other ages may be used depending on the design and clinical relevance of the experiment. To acquire syngeneic blood, the donors must
be from the same C57BL/6 strain. The blood is held
in a non-heparinized 50 mL Falcon tube on ice less
than 5 min before placing 30 µL of whole blood or
serum onto the media that is already in the well, over
the VZ cell cultures. This step is carried out under the
laminar flow cabinet in sterile conditions to mimic
a bleeding process. Room temperature PBS 7.4 was
used as control. To select a specific developmental
time, consider that the cells are mostly NSC by 3 to
7 days, and mostly EC from 7 days-onward [32].
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In vitro model interpretation
While nearly any experimental method can be used in
this model, to date we have primarily employed two analytical techniques:
Western blot (WB)

• Rinse the cells three times with PBS. Add 60 µL RIPA
(radioimmunoprecipitation assay buffer) solution
(#R0278 Sigma, St.Louis, MO) onto the cells and
carefully pipet multiple times (~ 10) to homogenize
the cells. (Notice that WB requires a high concentration of proteins, therefore 10 × 104 cells were plated
for our VZ development; see step [For further analysis by western blot,…] in “Procedure” section. With
this amount, it is possible to perform 3 mini gels WB
per well of cells (loading ~ 20 µL of sample).
• Established WB routines can be followed to perform
this technique; see Castaneyra et al. [32] and the list
of antibodies used are available in Table 1.
Immunohistochemistry (IHC)

• Rinse the cells three times with PBS, fix the cells cultured on coverslips with 4% paraformaldehyde in
PBS PH 7.4 for 7 min. Wash three times with PBS to
remove the remaining fixative. Note, that the fixative used should be optimized for the antibodies
employed for IHC.

• Permeabilize the cells with 5% Bovine Serum Albumin in PBS, 1% Triton X-100 for 1 h.
• Established IHC routines can be followed to perform IHC, see [30, 32]. The list of antibodies used are
available in Table 1.

Image analysis
The immunofluorescent images were taken using Pascal confocal microscopy (Oberkochen, Germany). The
roundness plug-in of ImageJ (NIH public software) was
used to quantify the morphology of the cells labeled with
anti-GFAP (see Additional file 1: Figure S1). The roundness is a magnitude that ranges from 1 when the shape
is a perfect sphere to 0 when it is a line. For WB images,
the molecular imager Chemidoc XRS and image lab 3.0
software were used to quantify band density (Bio-Rad,
Hercules, CA).
Statistical analysis
Student’s t test or Mann–Whitney U-test were used for
parametric or non-parametric data respectively.
Results
EC differentiation

VZ cells in vitro progressively differentiate from monociliated NSC to multiciliated EC [30, 32]. To define the
development of the EC and monitor the validity this IVH
in vitro model, we used well-known VZ/EC markers

Table 1 Immunohistochemical markers used to investigate ventricular zone and stem cells biology
Antibody

Host species

Dilution IHC

Dilution WB

Source

GFAP

Rabbit

1:300

1:1000

#7260, Abcam

βIV tubulin

Mouse

1:100

–

#11315, Abcam

AQP4

Rabbit

1:1000

–

#PAB 20767 Abnov

β-catenin

Mouse

1:100

–

#Ab16051 Abcam

S100β

Rabbit

1:100

–

#Ab52642, Abcam

N-cadherin

Mouse

1:25

1:50

#180224, Thermo Fisher Scientific

EMA

Mouse

1:100

–

#790-4463, Roche

Β-actin

Rabbit

–

1:500

#2118S, Cell Signaling Technology

Mouse

–

1:500

#A1978 Sigma

Antimouse Alexa fluor 555

Goat

1:300

–

#AQ21422, Thermo Fisher Scientific

Antirabbit Alexa Fluor 488

Goat

1:300

–

#A11034, Thermo Fisher Scientific

Peroxidase-conjugated antirabbit

–

–

1:10,000

#70,742, Cell Signaling Technology

Peroxidase-conjugated antimouse

–

–

1:5000

#SC-2005, Santa Cruz Biotechnology

GAPDH

Abcam, Cambridge, UK
Abnova, Taipei, Taiwan
Thermo Fisher Scientific, Waltham, MA
Cell Signaling Technology, Danvers, MA
Santa Cruz Biotechnology, Dallas, TX
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(Table 1). Since EC represent a glial lineage, characteristic astrocytic cell markers such as GFAP and S100β
were present in the VZ (Fig. 2a–c′). S100β labels mature
ependymal cells [45] and GFAP labels NSC and immature EC [9, 10, 29, 46]. Cilia markers are also appropriate to discriminate between NSC (monociliated) and EC
(multiciliated) [47]. Double labeling with GFAP and βIV
tubulin is appropriate in this model because allows distinction between NSC (if monociliated), immature EC (if
multiciliated and positive for GFAP) and mature EC (if
multiciliated and negative for GFAP) (Fig. 2a–b′). In this
model the cells also express other markers such as epithelial membrane antigen (EMA) and Aquaporin 4 (AQP4)
that show selective expression in mature ependymal cells
(Fig. 2d, e). VZ/EC also elaborate cell junction proteins
such as N-cadherin and β-catenin, indicating attachment
and viability of the cell [48]; these proteins are expressed
in both NSC and EC (Fig. 2c–d′). An increase in multiciliated ependymal cells over time is detected in control
conditions (Fig. 2a–b′ and f ). To confirm this, we quantified the percentage of cells expressing EMA on days 5
(37.51 ± 11.38), 6 (42.93 ± 10.77), and 7 (58.15 ± 10.66)
(Fig. 4e, f ); these percentages were similar to those previously reported by our group [32].
Representative results of cell junction pathology

Impairment of cell junctions is a cardinal feature of IVHrelated VZ disruption in human infants [29] and our
in vitro model faithfully reproduces this phenomenon,
with a decrease in the expression of N-cadherin after 48 h
of blood exposure. Figure 3a–b′ illustrates the typical
expression of adherens junctions in control (PBS) compared to blood-exposed cultures. There is diminution
and dislocation of N-cadherin in blood-treated cultures,
while control cultures show a characteristic polygonal
shape as previously reported [42]. This model also allows
the use of quantitative techniques such as WB to quantify targets of interest to understand this disease; Fig. 3c
shows representative results of n-cadherin expression
normalized with the expression of GADPH after 48 h in
control and IVH conditions. In this case significant differences are found in the ratio of N-Cad/GADPH in control (0.66 ± 0.07) vs blood (0.30 ± 0.04) p < 0.05.
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Ventricular zone disruption and glial activation

Periventricular gliosis is another important feature of
IVH/PHH in humans and in vivo models, and the VZ
culture model also consistently demonstrates such glial
activation [10, 29]. VZ disruption itself represents an
alteration in the NSC/EC with a loss or detachment of
these cells, followed by astroglial proliferation. Figure 4
shows a representative IHC in which a decrease in multiciliated EC, labeled with βIV tubulin, is present after 48 h
of blood induction. The decrease of EC was confirmed by
quantifying the expression of EMA after 3, 24 and 48 h
in control VS the blood condition (3 h: 37.51 ± 11.38 VS
28.94 ± 11.14; 24 h: 42.93 ± 10.77 VS 18.18 ± 9.493; 48 h:
58.15 ± 10.66 VS 25.03 ± 16.31). Significant differences
were observed at 24 and 48 h (p < 0.001) (Fig. 4e, f ). There
was also a change in the morphology of the cells expressing GFAP, with branch-like projections resembling reactive astrocytes (Fig. 4a–b′). To identify this astrocytosis,
the morphology (roundness, measured using an ImageJ
software application) of the cells seems to be a reliable
variable in which the values close to 1 define a perfect
sphere compared to values close to 0 which indicate a
completely flat profile. Figure 3c shows a graphical representation of the roundness, being significantly lower
after blood induction compared to control (respectively
0.44 ± 0.01 vs 0.53 ± 0.01 p < 0.001) due to the increase
of elongated projections in blood conditions. The levels
of GFAP can also be quantified through WB. Figure 3d
shows results from a single WB of control compared to
blood, in which an increase in the ratio of GFAP/β actin
was found after 48 h of blood (control; 0.87 ± 0.16 vs
blood; 1.60 ± 0.44), confirming that blood increases the
amount of GFAP in the VZ. Other Inflammatory markers
may be used to more completely understand these cytopathological mechanisms.

Discussion
Despite the high prevalence and poor outcomes of PHH,
the pathogenesis of this disorder remains poorly understood [49, 50]. One major factor limiting scientific progress in this field is a lack of appropriate models to
probe the basic biology of the disease and to test novel
therapeutic strategies. The current effort describes the

(See figure on next page.)
Fig. 2 In vitro EC differentiation and characteristic markers: a, b Representative cell culture at day 5 and 7 respectively, labeled with anti-βIV (red)
tubulin and anti-GFAP (green), in which a remarkable increase in βIV tubulin expression occurs at day 7. a′, b′. High magnification (×63) of the VZ
at day 5 and 7 respectively. At day 7 the expression of βIV corresponds to multiciliated EC while at day 5 the labeling is linked to monociliated NSC.
The inset in A’ shows a magnification of a monociliated NSC (arrow). The insets in B’ shows a multiciliated EC expressing GFAP (arrowhead) and a
multiciliated EC not expressing GFAP (asterisk). c, c′. Representative VZ at day 7 immunolabeled with anti-S 100 β (green, associated with EC) and
N-Cad (red, associated with both EC and NSC). d, d′. In vitro VZ at day 7 labeled with AQP4 (green) and β-Catenin (red). e. High magnification (×63)
of the VZ labeled with EMA (mature EC marker). f. Schematic representation of the differentiation of the ependymal cells. Scale bars: a–d = 100 μm;
a′, b′ = 25 μm; c′, d′ = 20 μm
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Fig. 3 Cell junction impairments in the IVH in vitro model. a, b Comparisons of the expression of N-Cad at day 7 after 48 h of control (a) or blood
(b). a Shows higher intensity of N-Cad expression and b a clear lack of N-Cad expression. a′, b′ High magnification (×63) of a, b in which a′ shows
the typical lattice-like configuration of N-Cad vs b′ that shows fragmentation (arrowhead), dislocation (asterisk) and diminution of the expression
of N-Cad. c N-cad protein levels quantified by WB normalized with GADPH after 48 h of treatment; blood significantly decreases the expression of
N-Cad (P < 0.05). Data are mean values from relative units (n = 8). Scale bars: a, b = 100 μm; a′, b′ = 20 μm

protocol of the first in vitro model of preterm IVH/PHH
and represents a major step forward for investigators.
The in vitro IVH VZ model is a reliable tool to define
the biological mechanisms involved in this devastating
disorder.
To develop this model, an accurate isolation of the lateral wall of the lateral ventricle is a fundamental requirement. We have developed a straightforward and rapid
technique to dissect the lateral ventricle by using two
ultrafine forceps with just a single step to remove the
thalamus, the medial wall of the lateral ventricle, and the
hippocampus, versus the 5 steps previously described
([30, 31]).
The skull dissection must be done on cooled ice
(Fig. 1) to provide enough stiffness to the fresh brain tissue; otherwise, the tissue may lose its shape and attach
to the frontal and parietal bones complicating the bone
removal.
To obtain a cell culture that mimics the cellular composition of the VZ with fidelity it is critical to totally
remove the hippocampus and the meninges to prevent
proliferation of neuronal-committed cells and fibroblasts,
respectively. The cells are expanded for 3–5 days or until
confluence. At this time point the differentiated cells are
mechanically discarded. At the time the differentiation

media is added, the cultures are composes of undifferentiated NSC that correspond to newborn lateral wall VZ
development reported by Delgehyr et al. [30].
The most innovative process in this model is the addition of blood onto the cultured VZ to mimic the effects
IVH on maturing neuroepithelial/ependymal cells. It
is key to apply freshly obtained, whole blood onto the
VZ cells as soon as possible (i.e., within 5 min). Within
those 5 min, it is highly advised to keep the blood in
ice cooled 25 mL falcon tubes to prevent coagulation.
The presence of clots will impair pipetting the designated amount of blood onto the cells due to a pipet tip
obstruction.
Likewise, this model is useful for studying the bloodrelated VZ cytopathology but does not take into account
other physiological factors active in hydrocephalus
such as increased intracranial pressure, which has been
recently modeled using a 3-D neural cell cultures and a
newly developed pressure controlled cell culture incubator [51].
While other authors have shown in vitro congenital
hydrocephalus-dependent cytopathology [24, 42], this
technique is a highly specific method to study the cytological mechanisms involved in the VZ after IVH. In this
protocol paper, our aim is to describe our model [32] and

Castaneyra‑Ruiz et al. Fluids Barriers CNS

(2020) 17:46

Page 9 of 11

Fig. 4 Glial activation and VZ disruption in the IVH in vitro model. a, b Comparisons of the expression of GFAP and βIV tubulin at day 7 after 48 h
of control (a) or blood (b). a shows a qualitatively higher expression of βIV (arrows) and a lower expression of GFAP when compared to blood (b).
a′, b′ High magnification (×63) of a, b in which a′ shows several multiciliated EC (asterisk) vs b′ that shows a lack of multiciliated EC and changes
in the morphology of the VZ cells with the increase of GFAP projections (arrowhead), as well as dislocation (asterisk) and diminution of the
expression of N-Cad. c Graphical representation of the roundness of GFAP-labeled cells after 48 h of treatment (control vs. blood), In which the cells
are significantly less round in blood conditions (p < 0.001). Data are mean of the roundness of 2 different experiments with at least n = 10 d GFAP
protein levels quantified by WB normalized with β actin after 48 h of treatment, in which blood exposure increases the expression of GFAP. Data are
mean from a single experiment with n = 8. e Comparisons of the expression of EMA at day 5 after 3 h of treatment at day 6 after 24 h of treatment
and at day 7 after 48 h of treatment. The immunocytochemistry shows a decrease in the expression of EMA at 24 and 48 h after blood induction.
f Quantification of EMA-positive cells. After 24 and 48 h treatment the mean percentage of cells expressing EMA was significantly decreased. Data
are mean of the percentage of cells expressing EMA, from 2 experiments with at least n = 5 wells at 3, 24, and 48 hours, respectively (***p < 0.001;
Student t-test). Scale bars: a, b = 50 μm; a′, b′ = 10 μm; e = 20 μm
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show representative results. Despite only showing representative results from 3 to 48 h after blood induction,
this technique provides a high temporal-resolution tool
that opens the possibility to study the cellular response
within seconds or minutes, which is problematic in vivo.
This protocol also allows investigators to employ drugs to
modulate and understand normal VZ development compared to IVH conditions without in vivo impediments,
such us crossing the blood brain barrier in drug delivery
or tissue dissections.
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org/10.1186/s12987-020-00210-7.
Additional file 1: Figure S1. ImageJ macroinstruction used to quantify
the roundness of GFAP-positive cells. A. Code of the macroinstruction that
allows the quantification of the roundness of the cells in a single step. B.
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the macroinstruction. Note that the macroinstruction does not count cells
touching the edges of the image.
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